Standard BioTools Inc. (LAB) stock
LABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3087% below fair value
$0.54−0.08 (-13.14%)
Close on Nov 17, 2026Market cap $211.76MP/E 2.5Yield –
Standard BioTools total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
For fiscal 2012 it was $0, down 100.0% from the year before.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $0 | -100.0% |
| FY2011 | Dec 31, 2011 | $10.14M | -31.0% |
| FY2010 | Dec 31, 2010 | $14.70M | – |
See a number that looks wrong?